Table 4.

Changes in total cholesterol, LDL and HDL cholesterol, and triglycerides between baseline and follow-up

	Cilostazol		Control		p value
Total cholesterol (mg/dl)					0.557
Baseline	188.20	±41.34	190.42	±37.59
Follow-up	169.11	±35.53	167.69	±35.30
Mean change	–21.53	±43.01	–23.17	±48.95
HDL cholesterol (mg/dl)					0.006
Baseline	41.46	±11.00	40.51	±11.02
Follow-up	53.86	±15.00	46.95	±12.95
Mean change	11.50	±15.59	6.29	±10.82
Triglyceride (mg/dl)					0.212
Baseline	141.91	±70.43	149.37	±106.87
Follow-up	113.63	±54.23	141.76	±77.92
Mean change	–29.85	±65.23	–9.94	±105.99
LDL cholesterol (mg/dl)					0.838
Baseline	117.40	±35.68	118.08	±33.82
Follow-up	97.24	±31.40	100.83	±31.83
Mean change	–21.00	±35.07	–17.19	±42.56
HbA1c (%)					0.750
Baseline	6.05	±1.23	6.22	±1.37
Follow-up	6.31	±0.93	6.51	±1.38
Mean change	0.13	±1.18	0.19	±1.21

p value by two-way ANOVA adjusted for administration of statins